Electrochemistry of deferiprone as an orally active iron chelator and HIV-1 replication inhibitor and its determination

27Citations
Citations of this article
17Readers
Mendeley users who have this article in their library.

Abstract

The electrochemical behavior of the anti-thalassemia and anti-HIV replication drug, deferiprone, was investigated by cyclic voltammetry (CV) at a platinum electrode. In an acetate buffer solution, pH = 4.0, two irreversible anodic peaks for deferiprone, with E01 = 875 mV and E 02 = 1235 mV (vs. Ag/AgCl) appeared at a potential sweep rate of 50 mV s-1. Cyclic voltammetric study indicated that the oxidation process is irreversible and diffusion-controlled. The diffusion and the electron transfer coefficients of deferiprone were found to be 3.50 × 10-6 cm2 s-1 and 0.57, respectively. A sensitive, simple and time-saving differential pulse voltammetric procedure was developed. Using our proposed method, deferiprone can be determined with a detection limit of 1.43 × 10-5 mol L-1. The applicability of the method to direct assays of spiked human serum and urine fluids, and to commercial tablets, is described. ©2008 Sociedade Brasileira de Química.

Cite

CITATION STYLE

APA

Yadegari, H., Jabbari, A., Heli, H., Moosavi-Movahedi, A. A., & Majdi, S. (2008). Electrochemistry of deferiprone as an orally active iron chelator and HIV-1 replication inhibitor and its determination. Journal of the Brazilian Chemical Society, 19(5), 1017–1022. https://doi.org/10.1590/S0103-50532008000500029

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free